L(+)-Glutamic acid - ≥99% , CAS No.56-86-0

CAS: 56-86-0 Cat. No.: G103978 Fórmula: C5H9NO4 Peso molecular: 147.13 Beilstein Registry Number: 1723801 Número EC: 200-293-7
Disponible para pedir
CALIDAD & PUREZA ≥99%
Synonyms
glt|Glutamate, L-|Glutamic acid, (S)-|Glutaton|glutamate|L-Glutaminic acid|Gamma-L-Glutamic Acid|L-glutamic acid|(2S)-2-aminopentanedioate|(S)-Glutamic acid|L-alpha-Aminoglutaric acid|alpha-Aminoglutarate|GLUTAMIC ACID (EP MONOGRAPH)|Glutamic Acid [USAN:INN]|H-Glu-OH|Acido glutamico [INN-Spanish]|L-Glutamic adid|Acide glutamique (INN-French)|Acidum glutamicum|a-Aminoglutarate|(S)-2-Aminopentanedioic acid|glutaminic acid|Glutamic acid, L-|L-Glutamic acid (9CI)|alpha-Glutamic acid|Glusate|Glutamic acid (USP)|Glutaminic acid (VAN)|Acide glutamique [INN-French]|Acidum glutaminicum|a-Glutamate|L-(+)-glutamic acid|L(+)-Glutamic acid|L-glutamic-acid|Acide glutamique|L-Glutamic acid-13C5|D-Glutamiensuur|Glutamic Acid (L-glutamic acid)|Acido glutamico|aminoglutaric acid|L-Acido glutamico|.alpha.-Glutamic acid|[3h]-l-glutamic acid|Glutamic acid (H-3)|(L)-glutamic acid|Acidum glutamicum (INN-Latin)|a-Glutamic acid|glutacid|Pentanedioic acid, 2-amino-, (S)-|2-aminopentanedioate|glut|L-glu|(S)-glutamate|Glutamidex|L-a-Aminoglutarate|Aciglut|2-Aminoglutaric acid|L-2-Aminoglutaric acid|L-Glutamic,(S)|INS NO.620|GLUTAMIC ACID [EP MONOGRAPH]|1-amino-propane-1,3-dicarboxylic acid|1-Aminopropane-1,3-dicarboxylic acid|Acidum glutamicum [INN-Latin]|GLUTAMIC ACID [USAN]|L-Glutaminsaeure|(S)-2-AMINO-1,5-PENTANEDIOIC ACID|2-Amino-pentanedioic acid|GLUTAMIC ACID (USP-RS)|GLUTAMIC ACID [USP-RS]|Glutamicol|L-glutamate|Acido glutamico (INN-Spanish)|GLUTAMIC ACID|(2S)-2-Aminopentanedioic acid|a-Aminoglutaric acid|Glutamic acid (VAN)|L-alpha-Aminoglutarate|2-Aminopentanedioic acid, (S)-|alpha-Glutamate|L-2-amino-pentanedioic acid|2-Aminoglutarate|L-gluatmate|alpha-aminoglutaric acid|L-(+)-Glutamate
Storage
Room temperature,Desiccated
Shipped In
Normal
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
25g
G103978-25g
Fabricado bajo pedido · 8–12 semanas
8,59€
100g
G103978-100g
2 Disponible
Disponible ≥10
11,19€
250g
G103978-250g
—
5 Disponible
19,00€
500g
G103978-500g
—
3 Disponible
29,42€
Enter a quantity for the sizes you want to add.

Especificaciones

Sinónimos
glt | Glutamate, L- | Glutamic acid, (S)- | Glutaton | glutamate | L-Glutaminic acid | Gamma-L-Glutamic Acid | L-glutamic acid | (2S)-2-aminopentanedioate | (S)-Glutamic acid | L-alpha-Aminoglutaric acid | alpha-Aminoglutarate | GLUTAMIC ACID (EP MONOGRAPH) | Glutamic Acid [USAN:INN] | H-Glu-OH | Acido glutamico [INN-Spanish] | L-Glutamic Show more
Especificaciones y pureza
≥99%
Mecanismos bioquímicos y fisiológicos
Major excitatory neurotransmitter. Acts at glutamate receptors. Active in vivo .
Condiciones de almacenamiento de almacenamiento
Room temperature,Desiccated
Enviado en
Normal
Tipo de acción
ACTIVATOR
Nota
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Pureza
≥99%
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488183207
Sonrisas canónicas
C(CC(=O)O)C(C(=O)O)N
IUPAC Name
(2S)-2-aminopentanedioic acid
InChIKey
WHUUTDBJXJRKMK-VKHMYHEASA-N
INCHI
1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1
Isómeros SMILES
C(CC(=O)O)[C@@H](C(=O)O)N
WGK Alemania
1
Peso molecular
147.13
Beilstein
1723801
Reaxy-Rn
1723799
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1723799&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClaseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives
Direct ParentGlutamic acid and derivatives
Alternative Parents L-alpha-amino acids  Amino fatty acids  Dicarboxylic acids and derivatives  Amino acids  Carboxylic acids  Organopnictogen compounds  Organic oxides  Monoalkylamines  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic acyclic compounds
Substituents Glutamic acid or derivatives - Alpha-amino acid - L-alpha-amino acid - Amino fatty acid - Dicarboxylic acid or derivatives - Fatty acid - Fatty acyl - Amino acid - Carboxylic acid - Organic oxide - Primary amine - Organooxygen compound - Organonitrogen compound - Primary aliphatic amine - Organopnictogen compound - Carbonyl group - Organic oxygen compound - Amine - Organic nitrogen compound - Hydrocarbon derivative - Aliphatic acyclic compound
DescripciónThis compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
External Descriptors Common amino acids - Amino acids
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
SLC1A1 Tchem Excitatory amino acid transporter 3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIA4 Tclin Glutamate receptor 4 (5 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIK5 Tclin Glutamate receptor ionotropic, kainate 5 (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIK1 Tclin Glutamate receptor ionotropic, kainate 1 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIA2 Tclin Glutamate receptor 2 (5 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIA3 Tclin Glutamate receptor 3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIK2 Tclin Glutamate receptor ionotropic, kainate 2 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIK3 Tclin Glutamate receptor ionotropic, kainate 3 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM2 Tchem Metabotropic glutamate receptor 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM5 Tchem Metabotropic glutamate receptor 5 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM7 Tchem Metabotropic glutamate receptor 7 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM8 Tchem Metabotropic glutamate receptor 8 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIA1 Tclin Glutamate receptor 1 (4 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM3 Tchem Metabotropic glutamate receptor 3 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRM6 Tchem Metabotropic glutamate receptor 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FOLH1 Tclin Glutamate carboxypeptidase II (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM3 Tchem Metabotropic glutamate receptor 3 (732 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHAT Tchem Choline acetylase (63 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA3 Tclin Glutamate receptor ionotropic, AMPA 3 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM4 Tchem Metabotropic glutamate receptor 4 (2320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM6 Tchem Metabotropic glutamate receptor 6 (361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA1 Tclin Glutamate receptor ionotropic, AMPA 1 (277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA2 Tclin Glutamate receptor ionotropic, AMPA 2 (847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIK3 Tclin Glutamate receptor ionotropic kainate 3 (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM1 Tchem Metabotropic glutamate receptor 1 (2309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRM5 Tchem Metabotropic glutamate receptor 5 (5733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC1A1 Tchem Excitatory amino acid transporter 3 (527 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC1A3 Tchem Excitatory amino acid transporter 1 (586 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIK5 Tclin Glutamate receptor ionotropic kainate 5 (45 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACLY Tclin ATP-citrate synthase (168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIK1 Tclin Glutamate receptor ionotropic kainate 1 (340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSR Tclin Glutathione reductase (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIN1 Tchem Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (36611 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
tetX Tetanus toxin (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc17a1 Renal sodium-dependent phosphate transport protein 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm2 Metabotropic glutamate receptor 2 (1326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm8 Metabotropic glutamate receptor 8 (169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria4 Glutamate receptor ionotropic, AMPA 4 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik2 Glutamate receptor ionotropic kainate 2 (298 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc1a2 Excitatory amino acid transporter 2 (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grm7 Metabotropic glutamate receptor 7 (580 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
murI Glutamate racemase (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dapA Dihydrodipicolinate synthase (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc1a6 Excitatory amino acid transporter 4 (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ffp 4'-phosphopantetheinyl transferase ffp (24982 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc16a10 Monocarboxylate transporter 10 (73 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria2 Glutamate receptor ionotropic, AMPA (2103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grik1 Glutamate receptor ionotropic, kainate (722 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor; Grin1/Grin2b (1028 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate receptors; NMDA/AMPA (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor; Grin1/Grin2a (798 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor; Grin1/Grin2c (1127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vicia faba (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GAP1 General amino-acid permease GAP1 (481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gria2 Glutamate receptor AMPA 1/2 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Carbonic anhydrase-like protein, putative (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A085R Prolyl 4-hydroxylase (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

98 results found

Lot NumberCertificate TypeFechaArticulo
I2602554I2602554Certificate of AnalysisSep 14, 2026 G103978
I2602551I2602551Certificate of AnalysisSep 14, 2026 G103978
I2602549I2602549Certificate of AnalysisSep 14, 2026 G103978
I2602548I2602548Certificate of AnalysisSep 14, 2026 G103978
D2630385D2630385Certificate of AnalysisMay 29, 2026 G103978
D2630390D2630390Certificate of AnalysisMay 08, 2026 G103978
D2630389D2630389Certificate of AnalysisMay 08, 2026 G103978
D2630388D2630388Certificate of AnalysisMay 08, 2026 G103978
D2630383D2630383Certificate of AnalysisMay 08, 2026 G103978
A2621432A2621432Certificate of AnalysisJan 26, 2026 G103978
A2621433A2621433Certificate of AnalysisJan 26, 2026 G103978
A2621439A2621439Certificate of AnalysisJan 26, 2026 G103978
A2621442A2621442Certificate of AnalysisJan 26, 2026 G103978
G2614100G2614100Certificate of AnalysisJan 26, 2026 G103978
A2621443A2621443Certificate of AnalysisJan 26, 2026 G103978
A2621528A2621528Certificate of AnalysisJan 24, 2026 G103978
J2509416J2509416Certificate of AnalysisOct 27, 2025 G103978
J2509414J2509414Certificate of AnalysisOct 17, 2025 G103978
J2509412J2509412Certificate of AnalysisOct 17, 2025 G103978
J2509413J2509413Certificate of AnalysisOct 17, 2025 G103978
J2509415J2509415Certificate of AnalysisOct 17, 2025 G103978
L2523040L2523040Certificate of AnalysisOct 17, 2025 G103978
I2517189I2517189Certificate of AnalysisSep 19, 2025 G103978
F2519763F2519763Certificate of AnalysisJun 27, 2025 G103978
F2519723F2519723Certificate of AnalysisJun 27, 2025 G103978
F2519722F2519722Certificate of AnalysisJun 27, 2025 G103978
F2519721F2519721Certificate of AnalysisJun 27, 2025 G103978
F2519274F2519274Certificate of AnalysisJun 27, 2025 G103978
D2503579D2503579Certificate of AnalysisApr 08, 2025 G103978
D2503528D2503528Certificate of AnalysisApr 08, 2025 G103978
D2503583D2503583Certificate of AnalysisApr 08, 2025 G103978
D2503582D2503582Certificate of AnalysisApr 08, 2025 G103978
D2503271D2503271Certificate of AnalysisApr 08, 2025 G103978
D2503584D2503584Certificate of AnalysisApr 07, 2025 G103978
A2510409A2510409Certificate of AnalysisJan 21, 2025 G103978
A2510410A2510410Certificate of AnalysisJan 14, 2025 G103978
A2510408A2510408Certificate of AnalysisJan 14, 2025 G103978
A2510407A2510407Certificate of AnalysisJan 14, 2025 G103978
A2510317A2510317Certificate of AnalysisJan 14, 2025 G103978
A2510406A2510406Certificate of AnalysisJan 14, 2025 G103978
C2526005C2526005Certificate of AnalysisJan 14, 2025 G103978
L2425367L2425367Certificate of AnalysisDec 26, 2024 G103978
L2425368L2425368Certificate of AnalysisDec 26, 2024 G103978
L2425371L2425371Certificate of AnalysisDec 26, 2024 G103978
L2425491L2425491Certificate of AnalysisDec 26, 2024 G103978
L2425373L2425373Certificate of AnalysisDec 26, 2024 G103978
L2425376L2425376Certificate of AnalysisDec 26, 2024 G103978
I2413063I2413063Certificate of AnalysisJun 17, 2024 G103978
J2414387J2414387Certificate of AnalysisJun 17, 2024 G103978
F2405359F2405359Certificate of AnalysisJun 17, 2024 G103978
F2405363F2405363Certificate of AnalysisJun 17, 2024 G103978
F2405362F2405362Certificate of AnalysisJun 17, 2024 G103978
F2405361F2405361Certificate of AnalysisJun 17, 2024 G103978
F2405360F2405360Certificate of AnalysisJun 17, 2024 G103978
F2405358F2405358Certificate of AnalysisJun 17, 2024 G103978
C2413026C2413026Certificate of AnalysisMar 19, 2024 G103978
C2412033C2412033Certificate of AnalysisMar 14, 2024 G103978
C2414609C2414609Certificate of AnalysisMar 01, 2024 G103978
C2422205C2422205Certificate of AnalysisMar 01, 2024 G103978
C2422193C2422193Certificate of AnalysisMar 01, 2024 G103978
C2421400C2421400Certificate of AnalysisMar 01, 2024 G103978
C2421393C2421393Certificate of AnalysisMar 01, 2024 G103978
B2401107B2401107Certificate of AnalysisFeb 18, 2024 G103978
B2401111B2401111Certificate of AnalysisFeb 18, 2024 G103978
B2401110B2401110Certificate of AnalysisFeb 18, 2024 G103978
B2401108B2401108Certificate of AnalysisFeb 18, 2024 G103978
B2401109B2401109Certificate of AnalysisFeb 02, 2024 G103978
J2320396J2320396Certificate of AnalysisOct 24, 2023 G103978
J2320397J2320397Certificate of AnalysisOct 24, 2023 G103978
J2320419J2320419Certificate of AnalysisOct 24, 2023 G103978
J2307093J2307093Certificate of AnalysisOct 13, 2023 G103978
J2307088J2307088Certificate of AnalysisOct 13, 2023 G103978
L2325075L2325075Certificate of AnalysisOct 13, 2023 G103978
J2307092J2307092Certificate of AnalysisOct 13, 2023 G103978
J2307091J2307091Certificate of AnalysisOct 13, 2023 G103978
J2307090J2307090Certificate of AnalysisOct 13, 2023 G103978
F2329182F2329182Certificate of AnalysisJul 11, 2023 G103978
F2329157F2329157Certificate of AnalysisJul 11, 2023 G103978
F2329156F2329156Certificate of AnalysisJul 11, 2023 G103978
F2329155F2329155Certificate of AnalysisJul 11, 2023 G103978
F2329154F2329154Certificate of AnalysisJul 11, 2023 G103978
D2319517D2319517Certificate of AnalysisApr 25, 2023 G103978
D23191145D23191145Certificate of AnalysisApr 25, 2023 G103978
D23191231D23191231Certificate of AnalysisApr 25, 2023 G103978
D2319463D2319463Certificate of AnalysisApr 25, 2023 G103978
D2319472D2319472Certificate of AnalysisApr 25, 2023 G103978
D2319478D2319478Certificate of AnalysisApr 25, 2023 G103978
I2224396I2224396Certificate of AnalysisSep 30, 2022 G103978
I2224395I2224395Certificate of AnalysisSep 30, 2022 G103978
I2224393I2224393Certificate of AnalysisSep 30, 2022 G103978
I2224383I2224383Certificate of AnalysisSep 30, 2022 G103978
I2224382I2224382Certificate of AnalysisSep 30, 2022 G103978
D2301005D2301005Certificate of AnalysisSep 30, 2022 G103978
B2216308B2216308Certificate of AnalysisFeb 18, 2022 G103978
B2216322B2216322Certificate of AnalysisFeb 18, 2022 G103978
B2216312B2216312Certificate of AnalysisFeb 18, 2022 G103978
B2216328B2216328Certificate of AnalysisFeb 18, 2022 G103978
B2216329B2216329Certificate of AnalysisFeb 18, 2022 G103978
Propiedades químicas y físicas
SensibilidadMoisture sensitive.
Rotación específica [α]32 ° (C=5, HCl)
Punto de fusión (°C)205°C
Peso molecular147.130 g/mol
XLogP3-3.700
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass147.053 Da
Monoisotopic Mass147.053 Da
Topological Polar Surface Area101.000 Ų
Heavy Atom Count10
Formal Charge0
Complexity145.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Preguntas frecuentes y artículos
Synthesis and Metabolism of Glutamate and GABA: Core Mechanisms of Neurotransmitters
List of Natural Amino Acids
Bio-based Chemicals: From Platform Molecules to Application Scenarios — Trend Insights and Aladdin’s Product Portfolio
Structure, Function, and Applications of Glutamate Dehydrogenase
Key Enzymes in Amino Acid Metabolism: A Mechanistic Framework and Research Applications
G Protein–Coupled Receptors (GPCRs): Structure, Signaling, and Drug Targets
β-Acyloxy Alkenyl Amides (AAAs): A New Approach to Amide Bond and Peptide Bond Construction Worth Attention
Silicon Reagent-Assisted Peptide Synthesis: Research Progress and Methodological Value of Peptide Bond Formation from Unprotected Substrates
From Analytical Instrument to Synthetic Platform: A New Strategy for Reconstructing Automated Flow Solid-Phase Peptide Synthesis with Standard Analytical HPLC
Neurosteroids and Protective Mechanisms in the Central Nervous System
Molecular Basis of Ferroptosis-Immune Metabolism Crosstalk
Methods and Applications for the Determination of Amino Acid Content and Composition
Porous Graphitic Carbon (PGC) Chromatography Columns: Creating New Selectivity for Challenging Separations through Molecular Shape and the π-Electron Cloud on the Graphitic Surface
What Is Synthetic Biology? The Industrialization Pathway from Upstream Reagent Toolchains to Biomanufacturing Applications
Performance Sources and Formulation Applications of Enzyme-Based Ingredients in Daily Chemical Products: Fermentation Transformation, Enzymatic Reactions, and Application Principles
Analysis of Amino Acid-Based Surfactants: Basic Structure, Performance Origins, Category Selection, and Applications in Personal Care Formulations
Formation and Control of Carboxyl- and Hydroxyl-Related Impurities in Peptide Synthesis — Using Asp/Glu and Ser/Thr Residue Side Reactions as Examples
Neuropathological Mechanisms of Cerebral Infarction
TCA Cycle Metabolite Detection Methods and Result Interpretation
Mechanistic Analysis of Topical Glutathione in Skincare: Cellular Redox Regulation, Skin Delivery Challenges, and SLN-Based Delivery Strategies
Analysis of Hydrolyzed Pearl as a Cosmetic Raw Material: Preparation Process, Active Components, and Skincare Formulation Applications
Moisturizing Mechanism of Polyglutamic Acid: From the γ-Glutamyl Structure to Hydration Networks and Surface Film-Forming Behavior
Mechanisms by Which Fructan-Rich Ophiopogon japonicus Tuberous Root Extract Supports Skin Moisturization and Barrier Function
Structural Characteristics of Ergothioneine, OCTN1-Mediated Uptake by Skin Cells, and Antioxidant Mechanisms
Citations of This Product
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

No vendor-validated bioassay protocols (e.g., WB, IHC, IF, FC) apply to this small-molecule amino acid. General laboratory uses include:

  • Preparing glutamate buffers/salt solutions: dissolve the free acid and titrate to target pH with NaOH/KOH; filter-sterilize (0.22 µm) for biological applications.
  • Amino acid analysis standards: prepare accurately weighed stocks (e.g., 10–50 mM) in 0.1 M HCl to ensure stability; store aliquots at ≤4 °C.
  • Coupling reactions: for aqueous EDC/NHS activation, maintain pH 4.5–5.5 during activation and adjust to pH 7.5–8.5 for amine coupling.

For detailed, application-specific SOPs, adapt from standard peptide coupling or buffer preparation protocols and validate in-house. Item-specific recommended dilutions or positive controls are not applicable.

Biological Roles

General biochemical context (no medical claims):

  • Primary metabolism:

    • L-Glutamic acid is a central node in nitrogen metabolism, interconverting with α-ketoglutarate via glutamate dehydrogenase/transaminases, linking amino acid metabolism to the TCA cycle.
    • Precursor to γ-aminobutyric acid (GABA) via decarboxylation (glutamate decarboxylase) and to glutamine via glutamine synthetase.
  • Macromolecular roles:

    • Protein constituent: acidic residues (Glu) contribute to active sites, metal coordination, and electrostatic interactions; side-chain pKa (~4.1) influences protein pH-dependent behavior.
    • Polymer chemistry: forms poly(L-glutamic acid) and its esters, widely used in biomaterials and drug delivery research.
  • Signaling and transport (cell biology context):

    • Acts as a key excitatory amino acid neurotransmitter in many organisms; uptake and compartmentalization are tightly regulated by transporters and metabolic enzymes (biochemical statement; not a clinical claim).
  • Buffering/counterion functions:

    • Sodium/potassium glutamate solutions are used to stabilize proteins and macromolecular complexes by modulating ionic strength and specific ion effects.
  • Analytical standards:

    • Employed as a calibration standard for amino acid analyzers, LC methods (post-column ninhydrin or pre-column OPA/FMOC), and in isotope-dilution mass spectrometry (when isotopically labeled).
Buffer Applications

While the free acid itself is not a classic buffer across wide ranges, the glutamate/conjugate acid–base pairs provide useful buffering near its pKa values.

  • Relevant pKa values (literature):

    • α-COOH ~2.1 → buffering roughly pH 1.1–3.1
    • γ-COOH ~4.1 → buffering roughly pH 3.1–5.1
    • NH3+ ~9.5 → buffering roughly pH 8.5–10.5 (via acid–base pairing of the ammonium group)
  • Practical buffer systems (general guidance):

    • Sodium glutamate buffer (pH 3–5): prepare by partially neutralizing L-glutamic acid with NaOH to target pH using Henderson–Hasselbalch; typical working concentrations 10–100 mM.
    • Mixed buffers: combine sodium glutamate with acetate or citrate to enhance capacity in the pH 3.5–5 range without high ionic strength from chloride.
    • Alkaline glutamate buffer (pH 9–10): generate from monosodium/disodium glutamate and titrate with NaOH; suitable for certain enzyme assays that tolerate primary amines.
  • Laboratory tips:

    • Filter-sterilize (0.22 µm) instead of autoclaving if racemization or cyclization to pyroglutamate is a concern at high temperature.
    • Verify pH at working temperature/ionic strength; amino acid buffers can show temperature-dependent pKa shifts.

For stringent buffering at neutral pH, phosphate/HEPES/Tris are preferred; use glutamate primarily when specific ion effects are desired.

Green Alternatives

As a bio-based, readily available amino acid produced by fermentation, L(+)-glutamic acid already aligns well with green chemistry principles. Selection of form and process conditions can further improve sustainability.

  • Greenness profile (general):

    • Renewable feedstock: typically sourced via microbial fermentation of carbohydrates.
    • Low toxicity: minimal environmental persistence; readily biodegradable.
  • Process choices to enhance greenness:

    • Use aqueous media and glutamate salts to avoid high-boiling aprotic solvents (DMF/NMP). Favor EDC-mediated couplings in water or water/MeOH with NHS-esters where feasible.
    • Employ enzymatic transformations (e.g., selective esterification or amide formation using lipases) to reduce hazardous reagents and improve selectivity.
  • Comparison (general, literature-based):

    • Option: Free acid vs. protected derivatives
      • Free acid: avoids protecting-group reagents/steps; limited solubility may constrain throughput.
      • Protected derivatives (e.g., Fmoc-L-Glu(OtBu)-OH): enable high-efficiency SPPS but introduce protecting-group waste and use of dipolar aprotic solvents.
    • Option: Aqueous EDC/NHS vs. HATU/HBTU in DMF
      • Aqueous EDC/NHS: reduced solvent hazard; urea byproducts are water-soluble.
      • HATU/HBTU: high coupling efficiency but rely on hazardous solvents and generate guanidinium waste.
  • Practical tips:

    • Optimize pH (4.5–5.5) for carbodiimide couplings to minimize side-products and avoid excess base.
    • Recycle aqueous glutamate streams when feasible; salts are benign and can often be recovered.
Pharmaceutical Uses

No therapeutic claims are made. The following describes formulation/manufacturing roles in research and development contexts (general information):

  • Excipient/counterion roles:

    • Glutamate salts (e.g., arginine–glutamate, sodium glutamate) are employed to adjust pH, ionic strength, and to enhance protein solubility in biologics formulations.
    • Acts as a counterion for cationic actives in experimental salt screening, potentially improving crystallinity and handling.
  • Process aids:

    • Utilized in fermentation media as a nitrogen source or osmolyte.
    • Employed as a model acidic amino acid in compatibility studies (lyophilization, spray drying) to probe Maillard or lactamization risks.
  • Standards and controls:

    • Reference standard for amino acid analysis during peptide API manufacturing and for cleaning validation.
  • Regulatory notes (general):

    • Compendial monographs for glutamic acid exist in major pharmacopeias; specific compliance for this SKU is Not specified for this item; refer to CoA/Spec Sheet.
  • Practical considerations:

    • Monitor pH and temperature during processing to minimize conversion to pyroglutamic acid.
    • For parenteral research formulations, use high-purity, low-endotoxin grades and validate bioburden; such grade details are Not specified for this item; refer to CoA/Spec Sheet.
Physical Properties

Item-specific numerical specifications (mp, solubility, etc.) are not provided for this SKU; consult the CoA/Spec Sheet for guaranteed values.

  • From Product Data:

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/General reference (not a specification):

    • Physical state: typically a crystalline solid, often as a zwitterion in the solid state.
    • Melting/decomposition: often reported to decompose near 199–205 °C (literature; decomposition rather than a sharp melt).
    • Solubility: sparingly soluble in water near neutral pH; solubility increases appreciably under acidic (protonated amine) or basic (deprotonated carboxylates) conditions; forms highly soluble salts (e.g., sodium/potassium glutamate). Poorly soluble in most nonpolar organic solvents.
    • pKa values (literature, 25 °C, aqueous): pKa1 (α-COOH) ~2.1; pKa2 (γ-COOH) ~4.1; pKa3 (NH3+) ~9.5. Isoelectric point (pI) ~3.2.
    • LogP (XlogP3-AA, literature surrogate for partitioning): around −3 to −3.5, consistent with high hydrophilicity.
  • Practical notes:

    • Dissolution is facilitated by pH adjustment: use slight NaOH to make monosodium/disodium glutamate for rapid dissolution, or HCl for protonated forms.
    • Hygroscopicity is generally low to moderate; however, powders can adsorb moisture affecting weigh accuracy—desiccation is recommended as per storage guidance.
Quality and Grades
  • From Product Data:

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Guidance on typical grades (general information):

    • Reagent/ACS grade: suitable for most synthetic and analytical uses; controlled inorganic/organic impurities.
    • BioReagent/Cell culture grade: screened for bioburden/endotoxin and trace metals; useful when biological assays are sensitive to contaminants.
    • Amino acid analysis grade: emphasizes low UV-absorbing impurities and residual solvents; helpful for peptide synthesis or chromatographic standards.
  • Considerations for this compound type:

    • Optical purity (ee/er) is critical—L-configuration should be verified by chiral HPLC or derivatization (e.g., Marfey’s/DANSYL methods). If chirality matters, request documentation.
    • Water content (Karl Fischer) and ash/metal content can impact peptide coupling efficiency and catalytic studies; check CoA when these parameters are critical.
    • For SPPS, users often prefer protected derivatives (e.g., Fmoc-L-Glu(OtBu)-OH) with tight controls on identity and residual solvents; use this unprotected acid primarily for solution-phase transformations or as a reference standard.
  • Documentation:

    • Request CoA/Spec Sheet for exact assay, optical rotation, residual solvents, and impurity profile specific to SKU G103978.
Reaction and Applications

L(+)-Glutamic acid serves as a versatile chiral pool synthon and biochemical reagent.

  • Synthetic applications (general):

    • Peptide chemistry: base material for protected derivatives (e.g., Boc-/Fmoc-L-Glu(OtBu)-OH). The γ-carboxyl requires orthogonal protection to prevent side reactions and to enable selective ligations.
    • Lactamization: thermal or acid-catalyzed cyclization affords L-pyroglutamic acid (5-oxoproline), a useful intermediate in peptide and heterocycle synthesis.
    • Side-chain elaboration: conversion of the γ-COOH to amides, esters (e.g., benzyl, tert-butyl), or activation as mixed anhydrides for subsequent nucleophilic substitution.
    • Decarboxylation/reductive routes: transformations to γ-aminobutyric acid (GABA) analogs via Curtius/Schmidt or via ester/azide sequences (literature precedent).
  • Biochemical/analytical uses:

    • Standard for amino acid analysis and calibration (HPLC, ion-exchange chromatography), often after derivatization (OPA, FMOC-Cl, PITC/Edman).
    • Substrate or counterion in enzyme and protein stability studies; sodium glutamate is frequently used to modulate ionic strength and prevent aggregation.
  • Practical tips:

    • Drying: for moisture-sensitive couplings, azeotropically dry protected derivatives; the free acid can be vacuum-dried at ambient temperature.
    • Coupling: use water-compatible activators (EDC·HCl with NHS or HOAt/HOBt alternatives) if operating near aqueous conditions. In anhydrous DMF, HATU/HBTU are effective with DIPEA.
    • Stereointegrity: avoid harsh basic conditions and high temperatures that could promote racemization at the α-center; employ mild bases and short activation times.
Reaction Conditions

General, literature-based guidance for typical transformations of L(+)-glutamic acid (not item-specific specifications):

  • Amide/peptide coupling:

    • Solvent: anhydrous DMF, NMP, or DCM/DMF mixtures for protected derivatives; water/MeOH with EDC·HCl for aqueous-compatible couplings.
    • Activators/bases: HATU or HBTU (1.0–1.2 eq) with DIPEA (2–3 eq); or EDC (1.1–1.5 eq) with NHS/HOAt and pH 4.5–5.5 in aqueous buffers.
    • Temperature/time: 0–25 °C, 0.5–4 h typical for small-molecule couplings; monitor to avoid over-activation.
  • Esterification (protecting side chain):

    • tBu esters via tert-butanol and acid catalysts (e.g., TFA, BF3·Et2O) or via Boc anhydride derivatives; benzyl esters via benzyl alcohol and DCC/DMAP or via benzyl bromide after activation.
    • Hydrogenolysis (OBn removal): H2, Pd/C, MeOH/EtOH, rt–40 °C.
  • Cyclization to pyroglutamic acid:

    • Conditions: heating (e.g., 150–200 °C solid-state) or in refluxing toluene/xylene with acid catalysts; or using DCC-mediated intramolecular activation in aprotic solvents. Avoid prolonged high T to prevent racemization.
  • Bioconjugation via NHS esters:

    • Generate NHS ester of the γ-COOH (EDC/NHS, DMF), then react with amines (pH 7.5–8.5) in aqueous buffer; rapid coupling within minutes to hours at rt.
  • Analytical/QA:

    • Track ee by chiral HPLC; confirm identity via 1H/13C NMR in D2O with appropriate pH adjustment to sharpen signals; verify absence of pyroglutamate by LC-MS.

Adjust conditions based on scale, protecting groups, and substrate sensitivity.

Safety and Handling

Follow standard laboratory hygiene for handling amino acids. No item-specific GHS data are provided here; consult the SDS for authoritative hazard information.

  • From Product Data:

    • GHS Classification: Not specified for this item; refer to SDS.
    • Signal Word / H-statements / Pictograms: Not specified for this item; refer to SDS.
  • General safety (literature/typical for amino acids; not a specification):

    • Expected to be of low acute toxicity; may cause mechanical irritation to eyes/respiratory tract as dust.
    • Avoid dust formation and inhalation; use local exhaust when weighing large quantities.
  • PPE recommendations (good laboratory practice):

    • Safety glasses, lab coat, and suitable gloves (e.g., nitrile). Use a dust mask or work in a fume hood if airborne dust may form.
  • Incompatibilities and stability (general):

    • Stable under recommended storage (cool, desiccated, at room temperature).
    • Avoid strong oxidizing agents. At elevated temperatures, can cyclize to pyroglutamic acid (lactam formation) or decompose.
  • First-aid overview (general):

    • Inhalation: move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: rinse with water; remove contaminated clothing; seek medical advice if irritation continues.
    • Ingestion: rinse mouth; seek medical advice if unwell.

Always defer to the product SDS for definitive hazard classifications and response procedures.

Solvent Selection

As a zwitterionic, highly polar solid, L(+)-glutamic acid is not used as a solvent; instead, solvent selection pertains to its dissolution for reactions or formulations.

  • Aqueous systems (general guidance):

    • Water: limited solubility near neutral pH; increased solubility by adjusting pH below ~2.5 (protonated) or above ~5 (as monosodium/disodium glutamate). Buffer capacity near pKa values.
    • Buffers: acetate (pH 3.6–5.6) or phosphate (pH 6–8) can be combined with glutamate salts to tune ionic strength without salting-out sensitive proteins.
  • Organic co-solvents:

    • Poorly soluble in most aprotic organics (MeCN, THF, DCM). MeOH/EtOH offer limited solubility unless water is present. For coupling reactions, dissolve as the sodium salt in minimal water, then add miscible organic (DMF/DMSO) as co-solvent.
    • DMSO/DMF: can aid dissolution of salts or protected derivatives; avoid high water content during moisture-sensitive couplings.
  • When to choose alternatives:

    • For SPPS or anhydrous couplings, use protected derivatives (e.g., Fmoc/Boc with OtBu or OBn side-chain protection) that are soluble in DMF/NMP.
    • For biophysical studies requiring high concentration, prepare sodium/potassium glutamate solutions at desired pH; they are markedly more soluble than the free acid.
  • Quick comparison (general):

    • Free acid: best for acidic media or where buffering near pH ~3–4 is desired.
    • Glutamate salts: preferred for neutral/basic media, higher solubility, and protein compatibility.
Storage and Reconstitution
  • From Product Data (specific to this SKU):

    • Storage Conditions: Room temperature, Desiccated, Cool. Store tightly closed in a dry place; avoid humidity. Shipped under Normal conditions.
  • General storage guidance (amino acids):

    • Protect from prolonged heat and moisture to minimize cyclization to pyroglutamic acid and prevent caking. For long-term storage, a desiccator or dry cabinet is recommended.
  • Reconstitution (general guidance; not a specification):

    • Solubility strategy: dissolve in water with pH adjustment. For rapid dissolution, prepare monosodium/disodium glutamate by adding NaOH dropwise to reach desired pH (commonly pH 3–5 for acidic solutions or pH 7–9 for neutral/basic).
    • Typical stock solutions: 0.1–1.0 M in water (as glutamate salt) depending on pH and ionic strength constraints. Filter-sterilize (0.22 µm) if used in biological systems.
    • Stability of solutions: best used fresh; refrigerated storage (2–8 °C) for short periods (days) is common. For extended storage, prepare aliquots and freeze (−20 °C) to limit degradation; avoid repeated freeze–thaw.
  • Compatibility:

    • Avoid strong oxidants in solution. Check pH after temperature equilibration; amino acid solutions can exhibit pH drift with CO2 absorption.

Refer to the CoA/SDS for any additional, item-specific handling notes.

Structure and Identity

A proteinogenic, chiral α-amino dicarboxylic acid with an additional γ-carboxylate side chain. L(+)-Glutamic acid is the L-enantiomer used broadly as a chiral building block in peptide chemistry.

  • From Product Data:

    • SKU: G103978
    • Product Name: L(+)-Glutamic acid
    • CAS: 56-86-0
    • PubChem CID: 33032 (as provided)
    • InChIKey: 398809 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/Computed (general reference, not item-specific specifications):

    • Common molecular formula (literature): C5H9NO4
    • Formula weight (literature): 147.13 g/mol
    • SMILES (literature): NC@@HC(=O)O
    • InChIKey (literature): WHUUTDBJXJRKMK-VKHMYHEASA-N
    • Stereochemistry: Single stereocenter at the α-carbon, configuration S (L).
  • Structural features (general):

    • Functional groups: α-amino, two carboxylic acids (α- and γ-), enabling zwitterionic forms depending on pH.
    • Backbone: HOOC–CH(NH2)–CH2–CH2–COOH; side chain is a propionic acid substituent at the α-carbon.
    • 2D description: A central chiral α-carbon bearing –NH2, –H, –COOH, and a –(CH2)2–COOH side chain; no rings or heteroaromatic moieties.
Synthetic Utility

The bifunctional nature of L(+)-glutamic acid (one α-amino and two carboxyl groups) provides rich chemoselectivity for synthesis.

  • Functional group strategies (general):

    • Orthogonal protection: Fmoc/Boc at the α-amine; tert-butyl or benzyl esters at the γ- and/or α-carboxyl. Selective mono- vs di-esterification enables divergent routes.
    • Activation modes: carbodiimides (EDC/DIC), uronium/phosphonium (HATU/HBTU/TBTU), mixed anhydrides, or acid chlorides (via mild reagents to prevent racemization).
  • Named/representative transformations:

    • SPPS: incorporation as Fmoc-L-Glu(OtBu)-OH on solid support, followed by global or side-chain deprotection.
    • Cyclization to pyroglutamate (intramolecular amidation) under heat/acid catalysis; used to access 5-membered lactams and peptidomimetics.
    • Curtius/Schmidt pathways from carboxyl derivatives for access to amino alcohols and diamines.
    • Formation of activated esters (e.g., NHS esters) as intermediates for bioconjugation at the side-chain.
  • Retrosynthetic value:

    • Chiral pool source for building γ-substituted amino acids via side-chain functionalization (e.g., alkylation after temporary protection/activation).
    • Provides handles for late-stage diversification in peptide macrocyclizations (side-chain to N-terminus linkages) and in dendrimer synthesis via branching from the γ-carboxyl.
  • Practical notes:

    • Maintain mildly basic conditions (DIPEA ≤ 2 eq) and short activation to limit epimerization.
    • Use orthogonal protecting groups compatible with chosen cleavage conditions (acidolysis vs hydrogenolysis).
Target Specificity

Not applicable. This product is a small-molecule amino acid, not an antibody, enzyme, or affinity reagent. No target, clone, isotype, or species reactivity data apply. For usage context, see Reaction & Applications, Buffer Applications, and Biological Roles.

Preguntas frecuentes

What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store in a cool place, desiccated. Keep the container tightly closed with desiccant — the material is moisture-sensitive.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 56-86-0, the molecular formula is C5H9NO4, and the molecular weight is 147.13 g/mol. InChIKey WHUUTDBJXJRKMK-VKHMYHEASA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.